Catalyst
Slingshot members are tracking this event:
Alexion (ALXN) Expects EU and FDA Regulatory Submissions for Soliris in Refractory Myasthenia Gravis in Q1 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ALXN |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 09, 2017
Occurred Source:
http://news.alexionpharma.com/press-release/product-news/alexion-submits-us-and-eu-applications-seeking-approval-soliris-eculizuma
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
European Union, Fda, Soliris, Refractory Myasthenia Gravis, Regulatory Submissions
